Drug Shortage Report for TRIESENCE

Last updated on 2018-11-07 History
Report ID 65471
Drug Identification Number 02368676
Brand name TRIESENCE
Common or Proper name TRIESENCE 1ML SUSP
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAVITREAL
Packaging size 1ML
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-11-02
Actual start date
Estimated end date 2018-11-21
Actual end date 2018-11-06
Shortage status Resolved
Updated date 2018-11-07
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-11-07 French Compare
v10 2018-11-07 English Compare
v9 2018-11-03 English Compare
v8 2018-10-31 French Compare
v7 2018-10-31 English Compare
v6 2018-10-31 English Compare
v5 2018-10-26 French Compare
v4 2018-10-26 English Compare
v3 2018-10-26 English Compare
v2 2018-10-23 French Compare
v1 2018-10-23 English Compare